Cargando…

Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium

Stem cells hold promise for treating a wide variety of diseases, including degenerative disorders of the eye. The eye is an ideal organ for stem cell therapy because of its relative immunological privilege, surgical accessibility, and its being a self-contained system. The eye also has many potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, Hong, Goldberg, Jeffrey L., Chen, Shuyi, Li, Wei, Xu, Guo-Tong, Zhang, Kang, Nussenblatt, Robert B., Liu, Yizhi, Xie, Ting, Chan, Chi-Chao, Zack, Donald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813266/
https://www.ncbi.nlm.nih.gov/pubmed/27102165
http://dx.doi.org/10.3390/ijms17030415
_version_ 1782424279222059008
author Ouyang, Hong
Goldberg, Jeffrey L.
Chen, Shuyi
Li, Wei
Xu, Guo-Tong
Li, Wei
Zhang, Kang
Nussenblatt, Robert B.
Liu, Yizhi
Xie, Ting
Chan, Chi-Chao
Zack, Donald J.
author_facet Ouyang, Hong
Goldberg, Jeffrey L.
Chen, Shuyi
Li, Wei
Xu, Guo-Tong
Li, Wei
Zhang, Kang
Nussenblatt, Robert B.
Liu, Yizhi
Xie, Ting
Chan, Chi-Chao
Zack, Donald J.
author_sort Ouyang, Hong
collection PubMed
description Stem cells hold promise for treating a wide variety of diseases, including degenerative disorders of the eye. The eye is an ideal organ for stem cell therapy because of its relative immunological privilege, surgical accessibility, and its being a self-contained system. The eye also has many potential target diseases amenable to stem cell-based treatment, such as corneal limbal stem cell deficiency, glaucoma, age-related macular degeneration (AMD), and retinitis pigmentosa (RP). Among them, AMD and glaucoma are the two most common diseases, affecting over 200 million people worldwide. Recent results on the clinical trial of retinal pigment epithelial (RPE) cells from human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) in treating dry AMD and Stargardt’s disease in the US, Japan, England, and China have generated great excitement and hope. This marks the beginning of the ocular stem cell therapy era. The recent Zhongshan Ophthalmic Center Ocular Stem Cell Symposium discussed the potential applications of various stem cell types in stem cell-based therapies, drug discoveries and tissue engineering for treating ocular diseases.
format Online
Article
Text
id pubmed-4813266
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-48132662016-04-06 Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium Ouyang, Hong Goldberg, Jeffrey L. Chen, Shuyi Li, Wei Xu, Guo-Tong Li, Wei Zhang, Kang Nussenblatt, Robert B. Liu, Yizhi Xie, Ting Chan, Chi-Chao Zack, Donald J. Int J Mol Sci Conference Report Stem cells hold promise for treating a wide variety of diseases, including degenerative disorders of the eye. The eye is an ideal organ for stem cell therapy because of its relative immunological privilege, surgical accessibility, and its being a self-contained system. The eye also has many potential target diseases amenable to stem cell-based treatment, such as corneal limbal stem cell deficiency, glaucoma, age-related macular degeneration (AMD), and retinitis pigmentosa (RP). Among them, AMD and glaucoma are the two most common diseases, affecting over 200 million people worldwide. Recent results on the clinical trial of retinal pigment epithelial (RPE) cells from human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) in treating dry AMD and Stargardt’s disease in the US, Japan, England, and China have generated great excitement and hope. This marks the beginning of the ocular stem cell therapy era. The recent Zhongshan Ophthalmic Center Ocular Stem Cell Symposium discussed the potential applications of various stem cell types in stem cell-based therapies, drug discoveries and tissue engineering for treating ocular diseases. MDPI 2016-03-22 /pmc/articles/PMC4813266/ /pubmed/27102165 http://dx.doi.org/10.3390/ijms17030415 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Conference Report
Ouyang, Hong
Goldberg, Jeffrey L.
Chen, Shuyi
Li, Wei
Xu, Guo-Tong
Li, Wei
Zhang, Kang
Nussenblatt, Robert B.
Liu, Yizhi
Xie, Ting
Chan, Chi-Chao
Zack, Donald J.
Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium
title Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium
title_full Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium
title_fullStr Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium
title_full_unstemmed Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium
title_short Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium
title_sort ocular stem cell research from basic science to clinical application: a report from zhongshan ophthalmic center ocular stem cell symposium
topic Conference Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813266/
https://www.ncbi.nlm.nih.gov/pubmed/27102165
http://dx.doi.org/10.3390/ijms17030415
work_keys_str_mv AT ouyanghong ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT goldbergjeffreyl ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT chenshuyi ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT liwei ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT xuguotong ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT liwei ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT zhangkang ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT nussenblattrobertb ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT liuyizhi ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT xieting ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT chanchichao ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium
AT zackdonaldj ocularstemcellresearchfrombasicsciencetoclinicalapplicationareportfromzhongshanophthalmiccenterocularstemcellsymposium